Cloning of the gamma chain of the human IL-2 receptor
- PMID: 1631559
- DOI: 10.1126/science.1631559
Cloning of the gamma chain of the human IL-2 receptor
Abstract
A third subunit, the gamma chain, of the human interleukin-2 receptor (IL-2R) was identified, and a complementary DNA clone encoding this member of the cytokine receptor family was isolated. The gamma chain is necessary for the formation of the high- and intermediate-affinity receptors, which consists of alpha beta gamma heterotrimers and beta gamma heterodimers, respectively. The IL-2R on murine fibroblastoid cells can be internalized after binding IL-2 only if the gamma chain is present; alpha and beta are insufficient for internalization. Thus, the gamma chain is an indispensable component of the functional IL-2R.
Similar articles
-
Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression.Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8464-8. doi: 10.1073/pnas.90.18.8464. Proc Natl Acad Sci U S A. 1993. PMID: 8378320 Free PMC article.
-
Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.Science. 1989 May 5;244(4904):551-6. doi: 10.1126/science.2785715. Science. 1989. PMID: 2785715
-
Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways.Proc Natl Acad Sci U S A. 1993 May 1;90(9):4127-31. doi: 10.1073/pnas.90.9.4127. Proc Natl Acad Sci U S A. 1993. PMID: 7683423 Free PMC article.
-
Structure and function of IL-2 and IL-2 receptors.Behring Inst Mitt. 1992 Apr;(91):87-95. Behring Inst Mitt. 1992. PMID: 1524574 Review.
-
Interleukin-2 and the IL-2 receptor: new insights into structure and function.J Invest Dermatol. 1990 Jun;94(6 Suppl):27S-32S. doi: 10.1111/1523-1747.ep12875017. J Invest Dermatol. 1990. PMID: 1693645 Review.
Cited by
-
Mathematical model for IL-2-based cancer immunotherapy.Math Biosci. 2024 Jun;372:109187. doi: 10.1016/j.mbs.2024.109187. Epub 2024 Apr 2. Math Biosci. 2024. PMID: 38575057
-
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.Int Arch Allergy Immunol. 2024;185(3):286-300. doi: 10.1159/000533677. Epub 2023 Dec 12. Int Arch Allergy Immunol. 2024. PMID: 38086339 Free PMC article. Review.
-
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer.Cancer Gene Ther. 2023 Dec;30(12):1679-1690. doi: 10.1038/s41417-023-00674-3. Epub 2023 Nov 10. Cancer Gene Ther. 2023. PMID: 37949944 Free PMC article.
-
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.Sci Rep. 2023 Aug 22;13(1):13713. doi: 10.1038/s41598-023-40026-7. Sci Rep. 2023. PMID: 37608029 Free PMC article.
-
Cytokine signaling in chimeric antigen receptor T-cell therapy.Int Immunol. 2024 Feb 14;36(2):49-56. doi: 10.1093/intimm/dxad033. Int Immunol. 2024. PMID: 37591521 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
